{"title":"Hormone therapy reduces psychotic relapse risk in women of menopausal age","authors":"","doi":"10.1002/pu.31252","DOIUrl":null,"url":null,"abstract":"<p>Women of menopausal age with schizophrenia or schizoaffective disorder who used menopausal hormone therapy experienced a reduced risk of psychotic relapse compared with non-use, a study using a within-individual design has found. Relapse risk was decreased in women who initiated hormone therapy between the ages of 40 and 55.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 1","pages":"3"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31252","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Women of menopausal age with schizophrenia or schizoaffective disorder who used menopausal hormone therapy experienced a reduced risk of psychotic relapse compared with non-use, a study using a within-individual design has found. Relapse risk was decreased in women who initiated hormone therapy between the ages of 40 and 55.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
